Intrepid Financial Planning Group LLC Decreases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Intrepid Financial Planning Group LLC lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,513 shares of the company’s stock after selling 505 shares during the quarter. Intrepid Financial Planning Group LLC’s holdings in GE HealthCare Technologies were worth $900,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Envestnet Portfolio Solutions Inc. grew its holdings in GE HealthCare Technologies by 30.2% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 61,729 shares of the company’s stock valued at $4,826,000 after purchasing an additional 14,321 shares during the last quarter. Choate Investment Advisors boosted its stake in shares of GE HealthCare Technologies by 14.6% during the fourth quarter. Choate Investment Advisors now owns 3,714 shares of the company’s stock valued at $290,000 after purchasing an additional 472 shares in the last quarter. Natixis Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 1.9% during the fourth quarter. Natixis Advisors LLC now owns 387,400 shares of the company’s stock valued at $30,288,000 after purchasing an additional 7,329 shares in the last quarter. Frank Rimerman Advisors LLC lifted its position in GE HealthCare Technologies by 8.2% during the fourth quarter. Frank Rimerman Advisors LLC now owns 3,490 shares of the company’s stock valued at $273,000 after acquiring an additional 265 shares during the last quarter. Finally, Intact Investment Management Inc. lifted its position in GE HealthCare Technologies by 15.4% during the fourth quarter. Intact Investment Management Inc. now owns 900 shares of the company’s stock valued at $70,000 after acquiring an additional 120 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.6 %

Shares of GEHC stock opened at $81.97 on Friday. The stock has a market cap of $37.48 billion, a price-to-earnings ratio of 18.93, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The firm’s 50 day moving average price is $87.26 and its two-hundred day moving average price is $86.12.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on GEHC shares. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup raised their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.